U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Grindr Inc. GRND fell 18.4% to close at $10.00 amid continued volatility after the stock began trading following the completion of its combination with Tiga Acquisition Corp.
C4 Therapeutics, Inc. CCCC fell 16.2% to close at $7.86.
Aenza S.A.A. AENZ dipped 16% to settle at $2.10.
PagSeguro Digital Ltd. PAGS declined 14.6% to close at $10.26 after the company reported Q3 earnings results.
Maxar Technologies Inc. MAXR fell 11.2% to close at $23.11. On November 16, Chostar unit entered into amendment to contract with Maxar for the Jupiter 3 Satellite Program.
Caleres, Inc. CAL dropped 10% to close at $24.83. The company posted upbeat quarterly results on Tuesday.
Meta Materials Inc. MMAT declined 9.4% to close at $1.84.
Adaptimmune Therapeutics plc ADAP dropped 8.6% to close at $2.23.
Ebang International Holdings Inc. EBON dipped 8.6% to settle at $5.52. Ebang International recently reported a 30-for-1 reverse stock split.
Olink Holding AB (publ) OLK fell 8% to close at $22.08.
Repare Therapeutics Inc. RPTX fell 7.6% to settle at $15.86.
StoneCo Ltd. STNE dropped 7.1% to close at $10.44. StoneCo recently reported Q3 earnings results.
AngioDynamics, Inc. ANGO slipped 7% to close at $13.61.
Credit Suisse Group AG CS fell 6.4% to close at $3.83. Credit Suisse Group on Wednesday flagged a massive loss for the fourth quarter, as it goes about setting its house in order. Shareholders of embattled Credit Suisse approved a proposal to issue new equity on Wednesday.
Autodesk, Inc. ADSK shares fell 5.7% to close at $197.07. Autodesk posted in-line earnings for its third quarter, but issued weak guidance for the year.
Nordstrom, Inc. JWN shares fell 4.2% to settle at $21.69. Nordstrom posted upbeat earnings and sales results for its third quarter. The company said it expects full-year revenue growth to be between 5% and 7% and adjusted earnings to be between $2.30 and $2.60 per share.
(C) 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.